Search
+
    SEARCHED FOR:

    ANTHROPIC CLAUDE MODEL

    Adobe VP of global strategic partnerships Shilpa Anand on bringing creative tools to ChatGPT and Claude

    Adobe is expanding its AI partnerships by bringing creative tools to ChatGPT, Claude and Gemini while integrating third-party AI models into apps such as Photoshop and Premiere Pro. In an interview with ET Digital, Adobe VP Shilpa Anand explains how these integrations could reduce friction for creators, whether the company could build Disney-style AI models for Indian media companies, why some AI models may take longer to reach India and what happens to customer data when Adobe works with external AI partners.

    Anthropic IPO: Can Indian investors apply for Claude maker's $64 billion share sale? Check rules

    Anthropic, a prominent artificial intelligence company, is planning a significant IPO to raise up to $64.4 billion. The company, founded by former OpenAI executives, aims to attract global investors, including those from India. Indian investors can participate in the offering through overseas brokerage accounts after the listing occurs. While demand for the shares appears strong, most retail investors may miss the IPO allocation.

    Most large firms plan higher open-weight AI use to cap bills, study shows

    According to a recent Capgemini study, senior executives are increasingly embracing cost-effective open-weight AI models, with nearly 60% expecting to adopt them more extensively in the upcoming year. Many admit to overspending on AI initiatives, surpassing their budgets by an average of 24%. While open-weight models dominate traffic volumes, they represent a fraction of overall spending.

    Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery push

    Anthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to improve the efficiency of drug discovery, addressing complex challenges in medical research. Notable projects include redesigning therapeutic molecules and accelerating antibody designs for various diseases. Anthropic has also initiated its own research on rare childhood muscular dystrophies, targeting potential clinical trials by late 2028.

    Anthropic IPO: A $1.4 trillion bet on the future of AI
    Is the AI wheel broken? Julius Baer flags 3 variables shaping AI investments ahead of Anthropic IPO

    Anthropic’s proposed $1.4 trillion IPO valuation will put the economics of the AI industry under the spotlight. Julius Baer analysts identify three key variables investors should watch: demand growth, pricing power and computing costs. The listing could also establish a valuation benchmark for OpenAI’s expected 2027 IPO.

    The Economic Times
    BACK TO TOP